EU Position Paper on AMR: Opportunities Beyond The General Pharmaceutical Legislation
Executive Summary The EU is approaching a critical juncture in its response to antimicrobial resistance (AMR). With efforts around the world stalling, it remains one of the few regions with the technical ability, financial mechanisms and industrial base to be the world leader in novel antimicrobial development. However it is currently lagging behind. Both the recently published Life Sciences Strategy and Medical Countermeasures Strategy propose that Europe needs a toolbox of measures to...
.png)